1,1,1-三氟-2-苯基-3-丁炔-2-醇 | 99727-20-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1,1,1-三氟-2-苯基-3-丁炔-2-醇
• 中文别名: 2-苯基-1,1,1-三氟-3-丁炔-2-醇
• 英文名称: (R,S)-1,1,1-trifluoro-2-phenylbut-3-yn-2-ol
• 英文别名: 1,1,1-trifluoro-2-phenyl-but-3-yn-2-ol；1,1,1-trifluoro-2-phenylbut-3-yn-2-ol；HCCC(Ph)(CF3)OH；1-trifluoromethyl-1-phenyl propargyl alcohol；1,1,1-Trifluoro-2-phenyl-3-butyn-2-ol
• CAS: 99727-20-5
• 化学式: C₁₀H₇F₃O
• mdl: MFCD00792447
• 分子量: 200.16
• InChiKey: WWIJKFJKIOQDKI-UHFFFAOYSA-N

物化性质

• 沸点：
  202.1 °C(lit.)
• 密度：
  1.301 g/mL at 25 °C(lit.)
• 闪点：
  199 °F
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2906299090
• 安全说明：
  S26,S37/39
• 储存条件：
  存于阴凉干燥处

SDS

Name:	1 1 1-Trifluoro-2-Phenylbutyn-2-ol Material Safety Data Sheet
Synonym:	alfa-Ethynyl-alfa-Trifluoromethylbenzyl Alcohol
CAS:	99727-20-5

Section 1 - Chemical Product MSDS Name:1 1 1-Trifluoro-2-Phenylbutyn-2-ol Material Safety Data Sheet
Synonym:alfa-Ethynyl-alfa-Trifluoromethylbenzyl Alcohol

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
99727-20-5	1,1,1-Trifluoro-2-Phenylbutyn-2-ol	ca. 100	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Will burn if involved in a fire. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Remove all sources of ignition. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 99727-20-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 102 - 103 deg C @ 12 mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 96 deg C ( 204.80 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.301
Molecular Formula: C10H7F3O
Molecular Weight: 200.16

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Will not occur.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 99727-20-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1,1,1-Trifluoro-2-Phenylbutyn-2-ol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 99727-20-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 99727-20-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 99727-20-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1,1,1-三氟-2-苯基-3-丁炔-2-醇 在 4-二甲氨基吡啶 、 N-溴代丁二酰亚胺(NBS) 、 silver nitrate 作用下， 以 二氯甲烷 、 丙酮 为溶剂， 反应 20.0h， 生成 ((4-bromo-1,1,1-trifluoro-2-phenylbut-3-yn-2-yl)oxy)(tert-butyl)dimethylsilane
  参考文献：
  名称：

  通过原位氨基形成和碳氨化反应一键三组分制邻二胺

  摘要：

  据报道，邻位二胺通过原位氨基形成和烯丙基胺的碳氨化而合成。采用稳定的血红素形式的高度贫电子的三氟甲基亚胺是实现快速，完整的氨基形成以及钯催化的碳氨化步骤的关键。所开发的条件允许引入具有完全区域选择性和高非对映选择性的各种炔基，乙烯基，芳基和杂芳基。该反应表现出较高的官能团耐受性。重要的是，咪唑烷产物中的任何一个氮原子都可以被选择性地脱保护，而在温和的条件下一步一步去除氨基链则可以显示出游离的二胺。我们希望这项工作将促进在有机合成中进一步使用混合的氨基系链。

  DOI：

  10.1002/anie.201607318
• 作为产物：
  描述：

  1,1,1-trifluoro-2-phenyl-4-(trimethylsilyl)but-3-yn-2-ol 在 甲醇 、 potassium carbonate 作用下， 以 二氯甲烷 为溶剂， 生成 1,1,1-三氟-2-苯基-3-丁炔-2-醇
  参考文献：
  名称：

  铜催化二烯醇合成 2-甲硅烷基-1,3-丁二烯及其在一锅法合成四取代芳基硅烷中的应用

  摘要：

  本研究报道了一种铜催化化学和立体选择性方法，使用温和的 Si-B 试剂从多种联烯醇合成 ( E )-2-甲硅烷基-1,3-丁二烯。我们的方案需要在环境温度下进行短反应时间才能以高产率产生所需的二烯。从联烯醇一锅合成四取代芳基硅烷以及 C-Si 键的进一步功能化突出了合成应用。

  DOI：

  10.1021/acs.orglett.3c03794

文献信息

• [EN] NAPTHALENE ACETIC ACID DERIVATIVES AGAINST HIV INFECTION<br/>[FR] DÉRIVÉS D'ACIDE NAPHTALÈNE ACÉTIQUE CONTRE L'INFECTION PAR LE VIH
  申请人：GILEAD SCIENCES INC

  公开号：WO2013103738A1

  公开（公告）日：2013-07-11

  The invention provides compounds and salts thereof as d herein. The invention also provides pharmaceutical compositions comprising a compound disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection, treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds disclosed herein.

  该发明提供了作为d的化合物及其盐。该发明还提供了包括本文所披露的化合物的药物组合物，用于制备本文所披露的化合物的过程，用于制备本文所披露的化合物的中间体，以及使用本文所披露的化合物治疗HIV感染、治疗HIV病毒的增殖、治疗艾滋病或延缓哺乳动物发生艾滋病或ARC症状的治疗方法。
• [EN] EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS<br/>[FR] POTENTIEL THÉRAPEUTIQUE ÉTENDU DANS DES ANTIMICROBIENS À NITROHÉTÉROARYLE
  申请人：UNIV CALIFORNIA

  公开号：WO2014205414A1

  公开（公告）日：2014-12-24

  Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to imidazole, thiazole, and furan derivatives and their use as therapeutic agents.

  本文披露了抗微生物化合物组合物、药物组合物及其使用和制备。一些实施例涉及咪唑、噻唑和呋喃衍生物及其作为治疗剂的用途。
• Transition‐Metal‐Free Radical Hydrotrifluoromethylation of Alkynes
  作者：Kiran Matcha、Andrey P. Antonchick

  DOI：10.1002/ejoc.201800291

  日期：2019.1.23

  A combination of readily available and bench‐stable CF3SO2Na and tBuOOH was efficiently used for hydrotrifluoromethylation of alkynes. An excellent trans‐selectivity was demonstrated in the synthesis of alkenes. The developed mild reaction conditions allow the supression of the competing Meyer–Schuster‐type rearrangement.

  容易获得且稳定的CF 3 SO 2 Na和t BuOOH的组合有效地用于炔烃的加氢三氟甲基化。在烯烃的合成中表现出优异的反选择性。发达的温和反应条件可以抑制竞争性的Meyer–Schuster型重排。
• [EN] THERAPEUTIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS THÉRAPEUTIQUES ET LEURS UTILISATIONS
  申请人：GENENTECH INC

  公开号：WO2016123391A1

  公开（公告）日：2016-08-04

  The present invention relates to compounds of formula (I): and to salts thereof, wherein R1-R6 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of TAF1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various TAF1-mediated disorders.

  本发明涉及式(I)的化合物及其盐，其中R1-R6具有规范中定义的任何值，以及其组合物和用途。这些化合物可用作TAF1的抑制剂。还包括包含式(I)的化合物或其药学上可接受的盐的药物组合物，以及在治疗各种TAF1介导的疾病中使用这些化合物和盐的方法。
• Construction of Chiral Tri‐ and Tetra‐Arylmethanes Bearing Quaternary Carbon Centers: Copper‐Catalyzed Enantioselective Propargylation of Indoles with Propargylic Esters
  作者：Kouhei Tsuchida、Yasushi Senda、Kazunari Nakajima、Yoshiaki Nishibayashi

  DOI：10.1002/anie.201604182

  日期：2016.8.8

  Copper‐catalyzed enantioselective propargylation of indoles with propargylic esters and sequential Huisgen cycloaddition with azides lead to the construction of chiral triarylmethanes, bearing a quaternary carbon center, with high to excellent enantioselectivities. The result described herein can be used in the enantioselective preparation of a tetraarylmethane.

  铜与炔丙基酯的铜催化对映体的对映选择性炔丙基化和与叠氮化物的连续惠斯根环加成反应导致手性三芳基甲烷的构建，其带有季碳中心，具有高至优异的对映选择性。本文所述的结果可用于对四芳基甲烷的对映选择性制备。